08.13.24
Supplementation with Safety Shot, a branded wellness beverage containing caffeine, B vitamins, and minerals, was associated with a faster rate at which alcohol is cleared from the body, according to an study the brand conducted in partnership with contract research organization Center for Applied Health Sciences (CAHS).
The study’s results are still being compiled into a manuscript, which will be submitted to a biomedical journal for peer review and publication.
The double-blind, randomized, placebo-controlled study evaluated how treatment with Safety Shot could impact both blood alcohol concentration (BAC) and other factors related to the metabolism of alcohol.
Participants between the ages of 24 and 46, who weighed between 95 and 225 pounds, experienced significantly greater rates at which alcohol was reduced and cleared from the body, ranging from 30-50% faster than placebo. These drops were measured in successive 30-minute increments.
Compared to placebo, the safety shot consistently lowered blood and breath alcohol content, as well as maximum concentrations for ethanol, acetaldehyde, and aldehyde dehydrogenase levels.
On a subjective level, participants reported significantly less head discomfort, reduced fatigue, increased energy levels, improvements in concentration, and reduced feelings of tiredness at multiple time points throughout the study.
“This marks a significant change in consumer behavior by providing a safer experience to consume alcohol, as well as better controlled drinking habits to allow for a healthier and more enjoyable environment for the consumer. We are thrilled to finally share the news that after nearly a decade of research and development, our study has successfully confirmed what we have seen in many of our own non-clinical trials," said David Sandler, chief operations officer and co-inventor. "These results are revolutionizing the wellness space as we continue to pioneer the world's most innovative functional beverages."
“These results are highly encouraging, showcasing Safety Shot’s potential as a beneficial supplement for individuals consuming alcohol,” said Tim Ziegenfuss, PhD, CSCS, FISSN, CEO of CAHS. “The observed reductions in breath and blood alcohol levels, along with the improvements in subjective feelings and physiological measures, highlight the promise of Safety Shot in supporting better outcomes in post-alchohol consumption.”
The study’s results are still being compiled into a manuscript, which will be submitted to a biomedical journal for peer review and publication.
The double-blind, randomized, placebo-controlled study evaluated how treatment with Safety Shot could impact both blood alcohol concentration (BAC) and other factors related to the metabolism of alcohol.
Participants between the ages of 24 and 46, who weighed between 95 and 225 pounds, experienced significantly greater rates at which alcohol was reduced and cleared from the body, ranging from 30-50% faster than placebo. These drops were measured in successive 30-minute increments.
Compared to placebo, the safety shot consistently lowered blood and breath alcohol content, as well as maximum concentrations for ethanol, acetaldehyde, and aldehyde dehydrogenase levels.
On a subjective level, participants reported significantly less head discomfort, reduced fatigue, increased energy levels, improvements in concentration, and reduced feelings of tiredness at multiple time points throughout the study.
“This marks a significant change in consumer behavior by providing a safer experience to consume alcohol, as well as better controlled drinking habits to allow for a healthier and more enjoyable environment for the consumer. We are thrilled to finally share the news that after nearly a decade of research and development, our study has successfully confirmed what we have seen in many of our own non-clinical trials," said David Sandler, chief operations officer and co-inventor. "These results are revolutionizing the wellness space as we continue to pioneer the world's most innovative functional beverages."
“These results are highly encouraging, showcasing Safety Shot’s potential as a beneficial supplement for individuals consuming alcohol,” said Tim Ziegenfuss, PhD, CSCS, FISSN, CEO of CAHS. “The observed reductions in breath and blood alcohol levels, along with the improvements in subjective feelings and physiological measures, highlight the promise of Safety Shot in supporting better outcomes in post-alchohol consumption.”
